https://www.selleckchem.com/pr....oducts/cathepsin-g-i
4.03. Results The median CA-125 before initiating OMT was 160 U/ml (range, 42.23-5330 U/ml). The median interval between last chemotherapy and starting OMT regimen was 159 days (range, 1-1211 days). The overall response rate was 50 per cent. The median progression-free survival (PFS) was 8.2 months [95% confidence interval (CI) 5.03-10.33], and the median overall survival was 38 months (95% CI 25.6-NR). Patients who received two lines of chemotherapy before OMT (P=0.052) and those who received pazopanib-based OMT (P=0.05
Like
Comment
Share
